Dependence of Wilms tumor cells on signaling through insulin-like growth factor 1 in an orthotopic xenograft model targetable by specific receptor inhibition

Guidelines for the welfare and use of animals in cancer research

(2010) P Workman et al.   BRITISH JOURNAL OF CANCER

Wilms tumor cells with WT1 mutations have characteristic features of mesenchymal stem cells and express molecular markers of paraxial mesoderm

(2010) Brigitte Royer-Pokora et al.   HUMAN MOLECULAR GENETICS

Wt1 ablation and Igf2 upregulation in mice result in Wilms tumors with elevated ERK1/2 phosphorylation

(2010) Qianghua Hu et al.   JOURNAL OF CLINICAL INVESTIGATION

Targeting Insulin-Like Growth Factor Signaling: Rational Combination Strategies

(2010) D. Olmos et al.   MOLECULAR CANCER THERAPEUTICS

Finding the tumor copycat: Approximating a human cancer

(2010) Terry Van Dyke   NATURE MEDICINE

Finding the tumor copycat: Therapy fails, patients don't

(2010) Lee M Ellis et al.   NATURE MEDICINE

Tumour-microenvironmental interactions: paths to progression and targets for treatment

(2010) Carol Box et al.   SEMINARS IN CANCER BIOLOGY

Molecular and Phenotypic Characterisation of Paediatric Glioma Cell Lines as Models for Preclinical Drug Development

(2009) Dorine A. Bax et al.   PLoS One

The Type 1 Insulin-Like Growth Factor Receptor Pathway

(2008) M. M. Chitnis et al.   CLINICAL CANCER RESEARCH

The type I insulin-like growth factor receptor pathway: a key player in cancer therapeutic resistance

(2008) Angelo et al.   Frontiers in Bioscience-Landmark

A Pathologic Link between Wilms Tumor Suppressor Gene, WT1, and IFI16

(2008) Marianne K-H. Kim et al.   NEOPLASIA

SK-NEP-1 and Rh1 are Ewing family tumor lines

(2006) Malcolm A. Smith et al.   PEDIATRIC BLOOD & CANCER